CFO4Life Group’s Edwards Lifesciences EW Stock Holding History

CFO4Life Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$231K	Buy	+2,548	New	+$213K	0.03%	214
2026 Q1	–	Sell	-3,653	Closed	-$311K	–	224
2025 Q4	$311K	Buy	+3,653	New	+$300K	0.04%	170
2021 Q4	–	Sell	-3,180	Closed	-$360K	–	160
2021 Q3	$360K	Buy	3,180 +300	+10%	+$34.2K	0.08%	105
2021 Q2	$298K	Hold	2,880	–	–	0.07%	110
2021 Q1	$241K	Hold	2,880	–	–	0.06%	128
2020 Q4	$263K	Hold	2,880	–	–	0.08%	122
2020 Q3	$230K	Buy	+2,880	New	+$225K	0.08%	113
2020 Q1	–	Sell	-2,880	Closed	-$224K	–	125
2019 Q4	$224K	Hold	2,880	–	–	0.09%	111
2019 Q3	$211K	Buy	+2,880	New	+$202K	0.09%	112

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CFO4Life Group's EW Position: Q2 2026 in Review

CFO4Life Group opened a new position in Edwards Lifesciences (EW) in Q2 2026: 2,548 shares worth $231K. The stake represents 0.03% of the portfolio and ranks #214 among its holdings. This is a return to the name: CFO4Life Group previously reported a position in EW as recently as Q4 2025.

CFO4Life Group first reported a position in EW in Q3 2019 and has held it in 9 quarters since. The position peaked at $360K in Q3 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

CFO4Life Group held 2,548 shares of Edwards Lifesciences worth $231K as of Q2 2026.
Edwards Lifesciences was a new CFO4Life Group position in Q2 2026.
Edwards Lifesciences made up 0.03% of CFO4Life Group's portfolio in Q2 2026, its #214 holding.
CFO4Life Group first reported a position in Edwards Lifesciences in Q3 2019 and has held it in 9 quarters since.
CFO4Life Group's Edwards Lifesciences position peaked at $360K in Q3 2021.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on CFO4Life Group's 13F filing for Q2 2026, filed 12 Aug 2026.